KDM6A and chronic myelomonocytic leukemia: Consistent with these findings, HSPCs derived from patients with CMML and subjected to KDM6A knockdown also showed increased p‐STAT3 levels and decreased SOCS3 protein expression (Figure S7A,B, Supporting Information).